Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Market Cap	3.54B
Revenue (ttm)	1.61B
Net Income (ttm)	517.39M
Shares Out	22.75M
EPS (ttm)	22.74
PE Ratio	6.84
Forward PE	n/a
Dividend	13.19 (8.48%)
Ex-Dividend Date	Oct 27, 2025

Volume	456,606
Average Volume	348,877
Open	155.54
Previous Close	155.54
Day's Range	155.60 - 159.00
52-Week Range	47.15 - 232.95
Beta	0.09
RSI	32.48
Earnings Date	Feb 9, 2026

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal ...

• Industry: Pharmaceutical Preparations
• Founded: 1940
• Employees: 144
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MPCI

Financial Performance

In 2025, EGX:MPCI's revenue was 1.51 billion, an increase of 72.93% compared to the previous year's 871.91 million. Earnings were 505.28 million, an increase of 163.91%.